These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19939766)

  • 1. [Preanalytical guidelines for clinical proteomics investigation of biological fluids].
    Lehmann S; Roche S; Allory Y; Barthelaix A; Beaudeux JL; Berger F; Betsou F; Borg J; Dupuy A; Garin J; Quillard M; Lizard G; Peoc'h K; Riviere M; Ducoroy P
    Ann Biol Clin (Paris); 2009; 67(6):629-39. PubMed ID: 19939766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Standard" protocol for evaluating the impact of preanalytical variables on peptidic and proteic analytes and standard coding of preanalytical procedures].
    Betsou F; Beaudeux JL; Berthelaix A; Borg J; Dupuy A; Lizard G; Peoc'h K; Quillard M; Lehmann S
    Ann Biol Clin (Paris); 2009; 67(6):641-9. PubMed ID: 19939767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Towards a standardization of the tools for the studies of clinical proteomics].
    Lucchi G; Hendra JB; Pecqueur D; Ducoroy P
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():19-22. PubMed ID: 17669348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of urine proteome in normal humans].
    Dobrokhotov IV; Pastushkova LKh; Larina IM; Nikolaev EN
    Aviakosm Ekolog Med; 2009; 43(3):3-10. PubMed ID: 19711855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer proteomics: many technologies, one goal.
    Conrads TP; Hood BL; Petricoin EF; Liotta LA; Veenstra TD
    Expert Rev Proteomics; 2005 Oct; 2(5):693-703. PubMed ID: 16209649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
    Thongboonkerd V
    Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
    Ransohoff DF
    J Clin Epidemiol; 2007 Dec; 60(12):1205-19. PubMed ID: 17998073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine proteomics biomarkers in renal transplantation: an overview.
    Quintana LF; Bañon-Maneus E; Solé-Gonzalez A; Campistol JM
    Transplantation; 2009 Aug; 88(3 Suppl):S45-9. PubMed ID: 19667961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva and the clinical pathology laboratory.
    Pesce MA; Spitalnik SL
    Ann N Y Acad Sci; 2007 Mar; 1098():192-9. PubMed ID: 17435128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
    Rai AJ; Vitzthum F
    Expert Rev Proteomics; 2006 Aug; 3(4):409-26. PubMed ID: 16901200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase in standardization and harmonization of the preanalytical phase in Europe.
    Cornes MP; Church S; van Dongen-Lases E; Grankvist K; Guimarães JT; Ibarz M; Kovalevskaya S; Kristensen GB; Lippi G; Nybo M; Sprongl L; Sumarac Z; Simundic AM;
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):539-47. PubMed ID: 27141012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre evaluation of the Bayer DAX system.
    Morosini L; Rossetti M; Berti P; Pallotti G; Fabbri V; Mambelli MC; Franceschin A; Dell'Anna L; Cappelletti P; Brocco G
    Eur J Clin Chem Clin Biochem; 1993 Dec; 31(12):875-96. PubMed ID: 8136420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A system to monitor a portion of the total testing process in medical clinics and laboratories: feasibility of a split-specimen design.
    Shahangian S; Krolak JM; Gaunt EE; Cohn RD
    Arch Pathol Lab Med; 1998 Jun; 122(6):503-11. PubMed ID: 9625417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic technologies for prenatal diagnostics: advances and challenges ahead.
    Choolani M; Narasimhan K; Kolla V; Hahn S
    Expert Rev Proteomics; 2009 Feb; 6(1):87-101. PubMed ID: 19210129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiplexed analysis for identification and evaluation of novel biomarkers in biological fluids, tissue and cell extracts].
    Lehmann S; Dupuy A; Beaudeux JL; Lizard G
    Ann Biol Clin (Paris); 2009; 67(4):381-93. PubMed ID: 19654078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.